MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
{{output}}
Glioblastoma (GBM) is an aggressive nervous system tumor with a poor prognosis. Although, surgery, radiation therapy, and chemotherapy are the current standard protocol for GBM patients, there is still a poor prognosis in these patients. Temozolomide (TMZ) as ... ...
